Published in Proc Natl Acad Sci U S A on September 02, 1997
Pathways towards and away from Alzheimer's disease. Nature (2004) 8.72
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med (2012) 3.31
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell (2010) 2.46
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics (2009) 2.36
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol (2011) 1.80
Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain (2011) 1.68
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci U S A (2004) 1.59
Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE. Nat Commun (2015) 1.57
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis (2010) 1.54
Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice. Learn Mem (2004) 1.43
Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res (2008) 1.38
Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling. PLoS One (2006) 1.37
Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29
Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis (2009) 1.29
Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci (2010) 1.29
Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res (2007) 1.28
Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol (2002) 1.26
Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J (1999) 1.25
Assessment of Alzheimer's disease case-control associations using family-based methods. Neurogenetics (2008) 1.23
Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur J Neurosci (2009) 1.23
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis (2009) 1.22
Abnormal brain iron homeostasis in human and animal prion disorders. PLoS Pathog (2009) 1.22
Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol (2005) 1.19
Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents. Magn Reson Med (2004) 1.19
Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue. Proc Biol Sci (2003) 1.18
Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm (Vienna) (2010) 1.15
Downregulation of CREB expression in Alzheimer's brain and in Aβ-treated rat hippocampal neurons. Mol Neurodegener (2011) 1.14
Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene. J Neurochem (2009) 1.14
Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One (2012) 1.13
Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev (2015) 1.13
Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis. Mol Biol Cell (2007) 1.13
Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease. J Med Genet (2004) 1.13
Role of metal dyshomeostasis in Alzheimer's disease. Metallomics (2011) 1.12
A delicate balance: Iron metabolism and diseases of the brain. Front Aging Neurosci (2013) 1.11
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease. Neurobiol Dis (2009) 1.11
Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method. Am J Pathol (1999) 1.10
Electron tomography of degenerating neurons in mice with abnormal regulation of iron metabolism. J Struct Biol (2005) 1.08
Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrin-bound and free iron into the rat brain. J Neurochem (2004) 1.08
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci (2015) 1.07
Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide. J Inorg Biochem (2008) 1.07
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging (2007) 1.06
Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity. J Biol Chem (2010) 1.06
Phosphorylated tau: toxic, protective, or none of the above. J Alzheimers Dis (2008) 1.05
Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int J Mol Sci (2012) 1.02
Neuroprotection against iron-induced cell death by perineuronal nets - an in vivo analysis of oxidative stress. Am J Neurodegener Dis (2012) 1.01
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta (2014) 1.01
Mitochondrial iron metabolism and its role in neurodegeneration. J Alzheimers Dis (2010) 1.01
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic Res (2009) 1.00
Genes involved in the balance between neuronal survival and death during inflammation. PLoS One (2007) 1.00
Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem (2008) 1.00
Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res (2005) 0.99
Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients. Biochim Biophys Acta (2006) 0.99
Causes of Alzheimer's disease. CMAJ (2000) 0.98
Nanoparticle and iron chelators as a potential novel Alzheimer therapy. Methods Mol Biol (2010) 0.98
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease. Front Aging Neurosci (2014) 0.98
Neuronutrition and Alzheimer's disease. J Alzheimers Dis (2010) 0.97
Iron and neurodegeneration: from cellular homeostasis to disease. Oxid Med Cell Longev (2012) 0.97
Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability. Biochemistry (2010) 0.97
Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Adv Pharmacol Sci (2011) 0.96
Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology (2011) 0.96
Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. Biochemistry (2009) 0.96
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies. J Alzheimers Dis (2008) 0.95
Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal (2013) 0.94
Crocetin reduces the oxidative stress induced reactive oxygen species in the stroke-prone spontaneously hypertensive rats (SHRSPs) brain. J Clin Biochem Nutr (2011) 0.94
Retinal iron homeostasis in health and disease. Front Aging Neurosci (2013) 0.94
Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. Brain Res (2008) 0.94
The role of zinc in Alzheimer's disease. Int J Alzheimers Dis (2010) 0.94
In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One (2013) 0.93
Redox control of prion and disease pathogenesis. Antioxid Redox Signal (2010) 0.93
Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy. Am J Pathol (1998) 0.91
The bad, the good, and the ugly about oxidative stress. Oxid Med Cell Longev (2012) 0.91
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. Brain (2012) 0.91
Iron and mechanisms of neurotoxicity. Int J Alzheimers Dis (2010) 0.91
Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation. Exp Neurol (2009) 0.91
The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Biophys J (2008) 0.90
Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level. Mol Neurodegener (2012) 0.90
Antimicrobial peptide β-defensin-1 expression is upregulated in Alzheimer's brain. J Neuroinflammation (2013) 0.90
Association between the c. 2495 A>G ATP7B Polymorphism and Sporadic Alzheimer's Disease. Int J Alzheimers Dis (2011) 0.90
Neuroprotective Effects of Centella asiatica against Intracerebroventricular Colchicine-Induced Cognitive Impairment and Oxidative Stress. Int J Alzheimers Dis (2009) 0.90
Hypothesis: soluble aβ oligomers in association with redox-active metal ions are the optimal generators of reactive oxygen species in Alzheimer's disease. Int J Alzheimers Dis (2010) 0.90
'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm (Vienna) (2007) 0.89
Iron accumulation during cellular senescence in human fibroblasts in vitro. Antioxid Redox Signal (2003) 0.89
Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis. Brain Res (2010) 0.89
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis (2013) 0.88
Cu(2+) affects amyloid-β (1-42) aggregation by increasing peptide-peptide binding forces. PLoS One (2013) 0.88
Identification of iron responsive genes by screening cDNA libraries from suppression subtractive hybridization with antisense probes from three iron conditions. Nucleic Acids Res (2000) 0.88
Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease? Oxid Med Cell Longev (2014) 0.88
The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease. Acta Neuropathol Commun (2013) 0.88
Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures. Oxid Med Cell Longev (2013) 0.87
Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci Lett (2007) 0.87
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. Int J Mol Sci (2009) 0.87
Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease. J Alzheimers Dis (2011) 0.87
Apotransferrin protects cortical neurons from hemoglobin toxicity. Neuropharmacology (2010) 0.87
Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol (1998) 0.87
Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction. PLoS One (2014) 0.86
Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates. J Phys Chem B (2010) 0.86
Age-dependent and gender-specific changes in mouse tissue iron by strain. Exp Gerontol (2009) 0.85
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A (1991) 3.85
Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci (1997) 3.08
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet (1996) 2.95
Oxidative damage in Alzheimer's. Nature (1996) 2.55
Radical AGEing in Alzheimer's disease. Trends Neurosci (1995) 2.32
A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res (1992) 1.69
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62
Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology (1988) 1.44
Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (1990) 1.43
["Diaminobenzidine black" as a new histochemical demonstration of exogenous iron (author's transl)]. Histochemistry (1980) 1.42
Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease. Am J Pathol (1992) 1.34
Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol (1992) 1.33
Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J Neurosci Res (1992) 1.30
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci (1991) 1.27
Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease. Nat Med (1995) 1.13
Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol (1993) 1.09
A specific stain for the detection of nonheme iron proteins in polyacrylamide gels. Anal Biochem (1992) 0.98
Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat Med (1996) 0.95
Chemical modification of glucosamine-6-phosphate synthase by diethyl pyrocarbonate: evidence of histidine requirement for enzymatic activity. Arch Biochem Biophys (1992) 0.92
Chondroitin sulfate proteoglycans are a common component of neuronal inclusions and astrocytic reaction in neurodegenerative diseases. Brain Res (1994) 0.90
Evidence for an essential lysyl residue in phospholipase D from Streptomyces sp. by modification with diethyl pyrocarbonate and pyridoxal 5-phosphate. Biochemistry (1996) 0.89
Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80
Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging (2001) 3.48
The family health worker. Am J Public Health Nations Health (1968) 3.34
Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci (1997) 3.08
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A (1987) 2.97
RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem (1997) 2.80
Oxidative damage in Alzheimer's. Nature (1996) 2.55
Radical AGEing in Alzheimer's disease. Trends Neurosci (1995) 2.32
Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31
Deception by young children following noncompliance. Dev Psychol (1999) 2.29
Trust hospitals and vascular services. BMJ (1994) 2.18
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol (1989) 2.07
Late complications after ligation and bypass for popliteal aneurysm. Br J Surg (2004) 2.07
Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04
Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91
Prepregnancy body mass index and pregnancy weight gain: associations with preterm delivery. The NMIHS Collaborative Study Group. Obstet Gynecol (2000) 1.91
Oxidative stress in Alzheimer's disease. Biochim Biophys Acta (2000) 1.84
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J Med Chem (1980) 1.80
Need for secondary interventions after endovascular repair of abdominal aortic aneurysms. Intermediate-term follow-up results of a European collaborative registry (EUROSTAR). Br J Surg (2000) 1.77
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol (1997) 1.71
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med (1995) 1.69
Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem (2001) 1.68
Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr (1992) 1.68
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem (1998) 1.68
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem (2001) 1.64
Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem (2000) 1.60
Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci (2007) 1.59
Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol (1992) 1.55
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci (1993) 1.54
Harmonization of vascular surgical training in Europe. A task for the European Board of Vascular Surgery (EBVS). Cardiovasc Surg (2000) 1.53
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem (2005) 1.53
Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest (1995) 1.52
Activation of NADPH oxidase in Alzheimer's disease brains. Biochem Biophys Res Commun (2000) 1.51
Comparative vascular audit using the POSSUM scoring system. Ann R Coll Surg Engl (1993) 1.51
Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles. J Neuropathol Exp Neurol (1988) 1.49
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport (1999) 1.49
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech Ageing Dev (2001) 1.47
Impact of study design on outcome after endovascular abdominal aortic aneurysm repair. A comparison between the randomized controlled DREAM-trial and the observational EUROSTAR-registry. Eur J Vasc Endovasc Surg (2006) 1.44
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol (2000) 1.42
Prospective randomised trial of distal arteriovenous fistula as an adjunct to femoro-infrapopliteal PTFE bypass. Eur J Vasc Endovasc Surg (1999) 1.42
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol (1990) 1.41
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A (1991) 1.41
Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem Res Toxicol (1995) 1.41
Reprinted article "Realistic expectations for patients with stent-graft treatment of abdominal aortic aneurysms. Results of a European multicentre registry". Eur J Vasc Endovasc Surg (2011) 1.40
Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1988) 1.40
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol (1990) 1.40
Adjuvant distal arteriovenous shunt with femorotibial bypass for critical ischaemia. Br J Surg (1983) 1.39
Oxidative stress signaling in Alzheimer's disease. Curr Alzheimer Res (2008) 1.38
The fate of elderly amputees. Br J Surg (1974) 1.37
Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients. Int J Radiat Oncol Biol Phys (2000) 1.37
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm (Vienna) (1998) 1.35
Redox-active iron mediates amyloid-beta toxicity. Free Radic Biol Med (2001) 1.35
Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes (1973) 1.34
Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet (1988) 1.33
Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol (1987) 1.32
Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol (2000) 1.31
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol (1998) 1.29
Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine. J Histochem Cytochem (1998) 1.27
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res (1998) 1.26
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles. Proc Natl Acad Sci U S A (1991) 1.26
Hibernation, a model of neuroprotection. Am J Pathol (2001) 1.24
Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol Disord Drug Targets (2007) 1.24
Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem (2000) 1.24
Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions. Carbohydr Res (1987) 1.23
Children's understanding of the distinction between real and apparent emotion. Child Dev (1986) 1.20
Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up. Eur J Vasc Endovasc Surg (2004) 1.20
Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem (1995) 1.20
Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. Antioxid Redox Signal (2000) 1.17
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. Ann Neurol (1988) 1.17
Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol (1998) 1.17
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem (2000) 1.16
Rupture of infra-renal aortic aneurysm after endovascular repair: a series from EUROSTAR registry. Eur J Vasc Endovasc Surg (2003) 1.16
Monitoring kinetic and frequency-domain properties of eyelid responses in mice with magnetic distance measurement technique. J Neurophysiol (2002) 1.15
Ultrastructural localization of erythrocyte cytoskeletal and integral membrane proteins in Plasmodium falciparum-infected erythrocytes. Eur J Cell Biol (1988) 1.15
A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys. Am J Trop Med Hyg (1992) 1.14
Hirano bodies contain tau protein. Brain Res (1987) 1.14
Undetected aorto-iliac insufficiency: a reason for early failure of saphenous vein bypass grafts for obstruction of the superficial femoral artery. Br J Surg (1975) 1.14
Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med (2001) 1.14